ACUTAAS CHEMICALS LIMITED

BSE: ACUTAAS543349ISIN INE00FF01025

Healthcare
Pharmaceuticals
BSE 500

BSE listing

Share price

₹3,438.15+122.55 (+3.70%)

as of 18 Sep 2026

52W high: ₹3,735.00
52W low: ₹1,290.05
Off 52W high: -7.95%
1M return: +6.47%
3M return: +5.99%
6M return: +42.91%
1Y return: +133.51%
20D avg volume: 33,225
50 DMA: ₹3,310.09
200 DMA: ₹2,593.43

Key ratios Consolidated

Market cap: ₹28,149 Cr
Current price: ₹3,438.15
52W high / low: ₹3,735.00 / ₹1,290.05
Face value: ₹5.00
P/E: 72.67
P/B: —
EPS (TTM): ₹47.31
Book value / share: —
ROE: —
ROCE: 27.70%
Operating margin: —
Net margin: —
Debt / equity: 0.02
Net debt: ₹-189.06 Cr
Interest cover: 148.62
Dividend yield: 0.07%
Dividend / share (TTM): ₹2.50
Payout: 5.28%
Cash conversion cycle: 119.9 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	329.68	432.75	393.18	306.20	207.24	308.48	274.99	246.73	176.67	224.96	166.44	172.36
	1.80	11.11	4.70	9.84	15.94	5.78	1.67	8.44	1.04	1.34	3.49	1.50
	227.57	260.06	253.21	219.85	165.10	231.43	213.32	205.13	157.76	188.77	146.24	152.05
	165.77	183.69	175.97	131.24	104.06	164.55	157.21	142.99	105.06	134.43	86.14	147.89
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	39.57	33.29	29.86	29.35	25.07	23.30	21.67	19.63	19.06	17.04	16.14	15.79
	1.14	1.19	0.86	0.58	0.64	0.60	0.69	0.50	4.43	2.07	2.54	0.82
	9.82	9.63	9.82	8.40	8.13	7.30	6.32	6.83	6.18	4.90	3.76	3.69
	38.28	51.51	43.50	46.07	34.37	37.74	36.84	38.62	25.77	29.75	28.79	—
	103.91	183.80	144.67	96.18	58.08	82.83	63.33	50.04	19.95	37.53	23.70	21.81
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.33	0.00	-31.75
	103.91	183.80	144.67	96.18	58.08	82.83	63.33	50.04	19.95	37.20	23.70	-9.94
	28.92	49.52	38.45	24.32	14.07	20.12	17.89	12.47	5.26	11.53	5.89	7.08
	74.99	134.28	106.22	71.86	44.01	62.72	45.45	37.57	14.69	25.68	17.81	-17.02
	9.07	16.09	13.19	8.82	5.41	7.80	11.35	9.38	3.67	6.86	4.83	-4.67
Key metrics
	114.87	194.62	155.35	105.16	66.85	90.73	70.34	57.37	30.56	44.17	30.00	-5.43
	34.80%	45.00%	39.50%	34.30%	32.30%	29.40%	25.60%	23.30%	17.30%	19.60%	18.00%	-3.20%
	22.70%	31.00%	27.00%	23.50%	21.20%	20.30%	16.50%	15.20%	8.30%	11.40%	10.70%	-9.90%
	—	10.60%	—	6.60%	—	6.20%	—	—	—	—	—	—
	59.10%	40.30%	43.00%	24.10%	17.30%	37.10%	65.20%	43.10%	—	—	—	—
	70.40%	114.10%	133.70%	91.30%	199.60%	144.20%	155.20%	320.70%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	1,462	1,339	1,007	717.48	616.74	520.13
	27.45	41.59	16.93	7.49	4.32	2.76
	960.69	898.23	807.64	610.98	508.88	431.45
	656.67	594.96	569.81	440.17	345.85	282.33
	0.00	0.00	0.00	—	—	—
	132.07	117.57	83.66	63.11	48.84	41.37
	3.77	3.27	6.22	5.94	2.41	6.41
	37.67	35.99	26.62	16.05	12.34	10.08
	179.36	175.44	138.97	114.18	114.40	100.76
	528.56	482.73	216.16	113.98	112.17	91.45
	0.00	0.00	0.00	-32.08	0.00	0.00
	528.56	482.73	216.16	81.90	112.17	91.45
	141.21	126.36	55.75	33.19	28.88	19.50
	387.35	356.37	160.42	48.71	83.29	71.95
	47.17	43.51	19.81	11.67	22.86	21.03
Key metrics
	570.00	521.99	249.00	103.89	126.92	107.94
	38.99%	39.00%	24.70%	14.50%	20.60%	20.80%
	26.50%	26.60%	15.90%	6.80%	13.50%	13.80%
	—	27.70%	16.50%	—	—	—
	—	33.00%	40.30%	16.30%	18.60%	—
	—	122.10%	229.30%	-41.50%	15.80%	—
	—	-35.81	-76.30	—	—	—
	—	0.82	0.74	—	—	—
	—	0.02	0.01	—	—	—
	—	-189.06	-177.04	—	—	—
	—	119.9	113.9	—	—	—
Balance sheet
	—	1,984	1,549	—	—	—
	—	881.27	791.64	—	—	—
	—	215.55	185.22	—	—	—
	—	362.56	290.49	—	—	—
	—	231.32	179.94	—	—	—
	—	—	0.00	—	—	—
	—	633.32	505.31	—	—	—
	—	153.91	156.05	—	—	—
	—	230.81	202.25	—	—	—
	—	26.49	8.18	—	—	—
	—	26.49	8.18	—	—	—
	—	0.00	0.00	—	—	—
	—	1,711	1,320	—	—	—
Cash flow
	—	292.17	118.34	—	—	—
	—	-265.94	-223.94	—	—	—
	—	4.10	261.12	—	—	—
	—	327.98	194.64	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	322.41	421.77	390.86	305.19	205.97	304.16	270.94	243.59	171.14	219.94	161.70	163.60
	4.48	14.55	6.34	8.97	16.02	5.69	2.17	8.58	1.90	8.55	2.87	1.26
	222.87	250.46	246.49	216.88	163.06	227.04	210.57	202.15	154.83	186.20	144.23	149.15
	163.97	183.27	176.02	130.03	103.18	163.21	157.33	141.66	104.64	133.15	85.43	146.12
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	37.40	31.33	26.97	28.64	24.40	22.61	20.92	18.96	18.46	16.36	15.54	15.34
	1.12	1.07	0.81	0.57	0.62	0.38	0.61	0.49	4.37	2.06	2.56	0.77
	9.02	8.83	9.02	7.72	7.46	6.56	5.67	6.20	5.62	4.36	3.50	3.40
	35.69	46.58	42.31	44.79	33.95	36.26	36.16	37.57	25.56	29.20	27.79	—
	104.02	185.86	150.71	97.28	58.93	82.81	62.54	50.02	18.20	42.29	20.34	15.71
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	-31.75
	104.02	185.86	150.71	97.28	58.93	82.81	62.54	50.02	18.20	42.29	20.34	-16.05
	28.12	48.79	39.14	24.39	14.28	19.97	17.24	12.34	4.49	10.21	4.64	4.91
	75.90	137.07	111.57	72.89	44.65	62.85	45.30	37.68	13.72	32.08	15.70	-20.96
	9.27	16.74	13.63	8.90	5.45	7.84	11.31	9.41	3.43	8.75	4.26	-5.75
Key metrics
	114.16	195.76	160.54	105.57	67.01	89.75	68.82	56.71	28.19	48.71	26.40	-11.88
	35.40%	46.40%	41.10%	34.60%	32.50%	29.50%	25.40%	23.30%	16.50%	22.10%	16.30%	-7.30%
	23.50%	32.50%	28.50%	23.90%	21.70%	20.70%	16.70%	15.50%	8.00%	14.60%	9.70%	-12.80%
	—	10.90%	—	6.70%	—	6.20%	—	—	—	—	—	—
	56.50%	38.70%	44.30%	25.30%	20.40%	38.30%	67.60%	48.90%	—	—	—	—
	70.00%	118.10%	146.30%	93.40%	225.40%	95.90%	188.50%	279.80%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	1,440	1,324	989.84	687.58	616.73	520.13
	34.34	45.88	18.34	13.79	4.32	2.76
	936.70	876.90	794.60	600.50	508.83	431.45
	653.29	592.50	566.84	434.96	345.85	282.33
	0.00	0.00	0.00	—	—	—
	124.34	111.35	80.95	60.92	48.84	41.37
	3.57	3.08	5.86	5.89	2.41	6.41
	34.59	33.03	24.05	14.69	12.34	10.08
	169.37	167.63	135.55	110.97	114.34	100.76
	537.87	492.77	213.58	100.86	112.22	91.45
	0.00	0.00	0.00	-31.75	—	—
	537.87	492.77	213.58	69.11	112.22	91.45
	140.44	126.60	54.03	25.43	28.88	19.50
	397.43	366.18	159.55	43.69	83.34	71.95
	48.54	44.73	19.91	11.91	22.87	21.03
Key metrics
	576.03	528.88	243.49	89.69	126.97	107.94
	40.00%	40.00%	24.60%	13.00%	20.60%	20.80%
	27.59%	27.70%	16.10%	6.40%	13.50%	13.80%
	—	29.00%	16.40%	—	—	—
	—	33.70%	44.00%	11.50%	18.60%	—
	—	129.50%	265.20%	-47.60%	15.80%	—
	—	109.89	-75.08	—	—	—
	—	0.83	0.73	—	—	—
	—	0.01	0.00	—	—	—
	—	-135.99	-178.26	—	—	—
	—	120.2	113.4	—	—	—
Balance sheet
	—	1,935	1,538	—	—	—
	—	808.96	771.31	—	—	—
	—	160.04	184.61	—	—	—
	—	360.18	289.21	—	—	—
	—	226.67	174.00	—	—	—
	—	50.70	0.00	—	—	—
	—	598.21	495.91	—	—	—
	—	150.84	155.54	—	—	—
	—	223.57	199.04	—	—	—
	—	24.05	6.35	—	—	—
	—	24.05	6.35	—	—	—
	—	0.00	0.00	—	—	—
	—	1,668	1,312	—	—	—
Cash flow
	—	305.37	115.93	—	—	—
	—	-333.61	-234.37	—	—	—
	—	3.68	273.56	—	—	—
	—	195.48	191.01	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +29.00%
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: +63.79%
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): +40.56%
Profit YoY (TTM): +108.65%

Consolidated

Sales CAGR 3Y: +29.50%
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: +62.34%
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): +40.91%
Profit YoY (TTM): +104.14%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 32.66%

Holder	Type	Holding	Previous	Change
Nareshkumar Ramjibhai Patel	Promoter	17.69%	—	—
Vaghasia Chetankumar Chhaganlal	Promoter	14.97%	—	—
Government Pension Fund Global	Public	3.54%	—	—
Kotak Mahindra Trustee Co Ltd A/C Kotak Multicap Fund	Public	3.53%	—	—
Dhwani Girishkumar Chovatia	Public	3.35%	—	—
Sbi Healthcare Opportunities Fund	Public	2.35%	—	—
Axis Max Life Insurance Limited A/C - Ulif01311/02/08lifehighgr104 - High Growth Fund	Public	2.19%	—	—
Vanaja Sundar Iyer	Public	1.14%	—	—
Hare Krsihna Impex	Promoter Group	0.00%	—	—
Rahil Infrastructure LLP	Promoter Group	0.00%	—	—
ACLEAN ENERGIES PRIVATE LIMITED	Promoter Group	0.00%	—	—
Sanjaykumar Ramnikbhai Thummer HUF	Promoter Group	0.00%	—	—
Hirenkumar Vijayabhai Dayani	Promoter Group	0.00%	—	—
PARULBEN VAGHASIA	Promoter	0.00%	—	—
ADHYAN VAGHASIA	Promoter Group	0.00%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 is attached.10 Sep 2026 · Company Update / General
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 in respect of inauguration of Pilot Plant today at Unit-1 Sachin is enclosed.4 Sep 2026 · Company Update / General
Newspaper publication for dispatch of notice of 19th AGM along with Annual Report for the FY 2025-26 is enclosed.31 Aug 2026 · Company Update / Newspaper Publication
Communication to shareholders issued in respect of deduction of TDS on Dividend , is herewith enclosed.29 Aug 2026 · Company Update / General
Intimation of Record date fixed for the purpose of Final Dividend for the FY 2025-26 is herewith enclosed.29 Aug 2026 · Corp. Action / Record Date
BRSR Report for the FY 2025-26 is herewith enclosed.29 Aug 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Annual Report for the FY 2025-26 is herewith enclosed.29 Aug 2026 · Others / Reg. 34 (1) Annual Report
Notice of the 19th Annual General Meeting of Company scheduled to be held on Thursday, September 24, 2026 at 11.30 A.M. IST is enclosed herewith.29 Aug 2026 · AGM/EGM / AGM
Press Release titled "Acutaas Chemicals'' step down subsidiary Indichem inaugurates Semiconductor Materials Plant at Gongju , The Republic of Korea", is attached.28 Aug 2026 · Company Update / Press Release / Media Release
Newspaper Publication in respect of 19th AGM of the company scheduled to be held on Thursday, September 24, 2026 is attached24 Aug 2026 · Company Update / Newspaper Publication
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 is attached.22 Aug 2026 · Company Update / General
We wish to inform you that, Ministry of Electronics and Information Technology has accorded its approval for the incentive package under the ECMS scheme as per the details attached18 Aug 2026 · Company Update / General
Schedule of Investor Meet is attached.8 Aug 2026 · Company Update / Analyst / Investor Meet
Transcript of Earnings Call Q1 FY27 financial results held on July 24, 2026 is enclosed.28 Jul 2026 · Company Update / Earnings Call Transcript
Newspaper publication of Unaudited Financial Results of the Company for the quarter ended June 30, 2026 as per details attached.25 Jul 2026 · Company Update / Newspaper Publication
Recording of the Earnings Call held on July 24, 2026 is enclosed24 Jul 2026 · Company Update / General
Investor Presentation on financial results for the first quarter ended June 30, 2026 is attached.24 Jul 2026 · Company Update / Investor Presentation
Press Release discussing the financial results of first quarter ended as on June 30, 2026 is attached.24 Jul 2026 · Company Update / Press Release / Media Release
Unaudited Financial Results for the quarter ended June 30, 2026 is enclosed.24 Jul 2026 · Result / Financial Results
The Board of Directors of the Company at their meeting held on Friday, July 24, 2026, inter alia, considered & approved Unaudited Standalone & Consolidated Financial Results of the Company ....24 Jul 2026 · Board Meeting / Outcome of Board Meeting
Intimation of Earnings conference call scheduled on July 24, 2026 at 04.00 P.M. (IST)20 Jul 2026 · Company Update / Analyst / Investor Meet
Acutaas Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 ,inter alia, to consider and approve Unaudited standalone & consolidated ....20 Jul 2026 · Board Meeting / Board Meeting
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulation, 2018 for the quarter ended June 30, 2026 is attached.10 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Nomination and Remuneration Committee at its meeting held today has approved designation of a Senior Management Personnel (SMP) of the Company as per details attached.2 Jul 2026 · Company Update / Change in Management
Closure of Trading Window26 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Disclosure under Regulation 30 of SEBI Listing Regulation is herewith enclosed.23 Jun 2026 · Company Update / General
Disclosure under Regulation 30 of SEBI Listing Regulation is herewith enclosed.22 Jun 2026 · Company Update / General
Intimation about Change in Status of Acutaas Chemicals Electrolytes Private Limited from Wholly Owned Subsidiary to Subsidiary of Acutaas Chemicals Limited19 May 2026 · Company Update / General
Information about resignation of Senior Management Person is attached herewith.18 May 2026 · Company Update / Cessation
Corporate Presentation which shall be discussed at the upcoming Investor Conferences/Meets is herewith enclosed.16 May 2026 · Company Update / Investor Presentation
Intimation of schedule of Conferences Meet as per details attached.14 May 2026 · Company Update / Analyst / Investor Meet
Transcript of Earnings Call for Q4 FY26 Financial Results held on April 30, 2026 is enclosed.6 May 2026 · Company Update / Earnings Call Transcript
Newspaper Publication of Standalone and Consolidated Audited Financial Results for the fourth quarter and year ended on March 31, 2026 is attached.1 May 2026 · Company Update / Newspaper Publication
Annual Secretarial Compliance Report for the financial year ended March 31, 2026 is attached.1 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Earnings Call Recording held on April 30, 2026 discussing the Q4 FY 26 financial results is herewith enclosed.30 Apr 2026 · Company Update / Analyst / Investor Meet
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....30 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Board approved the final dividend of Rs. 2.5/- (at the rate of 50%) per equity share of Rs. 5/- each fully paid for the FY 2025-26 subject to approval of shareholders in the ensuing AGM ....30 Apr 2026 · Corp. Action / Dividend
Investor Presentation on fourth quarter and year ended financial results as on March 31, 2026 is attached.30 Apr 2026 · Company Update / Investor Presentation
Press Release discussing the fourth quarter and year ended financial results as on March 31, 2026 is attached.30 Apr 2026 · Company Update / Press Release / Media Release
Audited standalone and consolidated financial results for the fourth quarter and year ended on March 31, 2026 is enclosed.30 Apr 2026 · Result / Financial Results

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 2.5000	17 Sep 2026	17 Sep 2026	—
Final Dividend - Rs. - 1.5000	18 Sep 2025	18 Sep 2025	—
Stock Split From Rs.10/- to Rs.5/-	25 Apr 2025	25 Apr 2025	—
Final Dividend - Rs. - 3.0000	13 Sep 2024	13 Sep 2024	—

Board meetings

24 Jul 2026 Board Meeting - Financial Results